Healthcare is moving toward more direct engagement between brands, providers, and patients. Manufacturer-led access programs are expanding, and large pharmaceutical companies are testing centralized patient portals that combine information, fulfillment,

Healthcare professionals encounter chronic pain in nearly every practice setting. Whether it is the patient in your exam room, a colleague struggling silently, or a family member whose life has

Oral peptide drugs are having a moment. FDA approvals in recent months include the first peptide pills for obesity and plaque psoriasis, each providing an alternative to injectable medications. Pinnacle

AI tools continue to flood the healthcare market, but not every startup will survive the hype cycle.  Uma Veerappan, a vice president at Flare Capital Partners, believes the companies achieving

Biogen is acquiring Apellis Pharmaceuticals in a $5.6 billion deal that brings two FDA-approved products commercialized in four indications, all of which are expected to contribute to the revenue growth

In healthcare, we preach infection control, emphasizing hand hygiene, surgical site sterility, and protective equipment. But there’s a silent risk too many hospitals overlook: contamination on lead aprons, which clinicians

EMS agencies everywhere are dealing with some tough challenges: overwhelmed crews, rising call volumes, and the never-ending need for accurate documentation. It’s quickly becoming clear that the old ways of

Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several

A federal inquiry into the financial and national security implications of pharmaceutical imports is leading President Trump to impose steep new fees, but they won’t touch the medicines that most

There’s a new lawsuit added to the growing list of legal challenges hospitals have brought against the way CMS calculates payments to facilities that treat a large share of Medicare